论文部分内容阅读
目的 :探析宫外孕采用米非司酮与甲氨蝶呤联合治疗的临床效果。方法 :选择2014年9月-2015年9月期间我院收治的宫外孕患者62例为研究对象,随机分为两组,其中给予对照组常规治疗,而观察组则运用米非司酮与甲氨蝶呤联合治疗,比较两组疗效。结果 :与对照组相比,观察组的治愈率明显较高,组间对比差异明显(P<0.05);同时,两组的阴道止血、腹痛消失、包块消失时间以及血β-HCG比较有统计意义(P<0.05)。结论 :临床上给予宫外孕患者甲氨蝶呤与米非司酮联合治疗,不仅可以提高治愈率,还可以使症状消失时间缩短,值得推广。
Objective: To investigate the clinical effect of combined treatment of mifepristone and methotrexate in ectopic pregnancy. Methods: Sixty-two patients with ectopic pregnancy who were treated in our hospital from September 2014 to September 2015 were selected and divided into two groups at random. The patients in the observation group were treated with mifepristone and methotrexate Pterin combined treatment, the two groups were compared. Results: Compared with the control group, the cure rate of the observation group was significantly higher, the difference between groups was significant (P <0.05); at the same time, vaginal bleeding, disappearance of abdominal pain, disappearance of mass and blood β-HCG Statistical significance (P <0.05). Conclusions: Combined treatment of methotrexate and mifepristone in patients with ectopic pregnancy can not only improve the cure rate, but also shorten the disappearance of symptoms and be worth popularizing.